Dermatology · Saint Paul, MN
NPI
1831208685
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3555 Willow Lake Blvd, Suite 240
Saint Paul, MN, 55110
Phone (651) 770-0110
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
3,865 services
Medicare patients, 2024
837
Average age 76
Drug cost, 2024
$1.4M
2,013 prescriptions
Company payments, 2025
$81.81
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert C Anderson was code 17003 (destruction skin lesion), 986 times for 225 patients. In total Robert C Anderson billed 3,865 services in 73 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 986 | 225 | $4.47 | $4,412 |
| 99213 Office E&M - Established | Office | 623 | 491 | $59.64 | $37K |
| 17000 Destruction Skin Lesion | Office | 407 | 317 | $35.65 | $15K |
| 88305 Surgical Pathology Examination | Office | 373 | 216 | $28.04 | $10K |
| 99214 Office E&M - Established | Office | 292 | 245 | $80.45 | $23K |
| 96910 Skin | Office | 221 | 19 | $93.49 | $21K |
| 11102 Skin Biopsy | Office | 208 | 180 | $64.95 | $14K |
| 17110 Destruction Skin Lesion | Office | 108 | 97 | $74.63 | $8,060 |
| 99203 Office E&M - New | Office | 72 | 72 | $68.46 | $4,929 |
| 11103 Skin Biopsy | Office | 58 | 41 | $37.96 | $2,202 |
| 99212 Office E&M - Established | Office | 47 | 41 | $37.32 | $1,754 |
| 99204 Office E&M - New | Office | 44 | 44 | $112.29 | $4,941 |
| 12032 Wound Repair - All Levels | Office | 43 | 42 | $233.93 | $10K |
| 11602 Skin Lesion Excision | Office | 32 | 32 | $91.72 | $2,935 |
| 17261 Destruction Skin Lesion | Office | 24 | 22 | $89.52 | $2,149 |
By year: 2022 $184K for 4,015 services; 2023 $181K for 3,778 services; 2024 $189K for 3,865 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 373 | 216 | $28.04 | $10K |
| 36415 Venipuncture Blood Collection | 15 | 13 | $8.65 | $130 |
| 88304 Surgical Pathology Examination | 13 | 12 | $23.51 | $306 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert C Anderson prescribed most often to Medicare patients was Ketoconazole, with 257 prescriptions and refills. In total Robert C Anderson wrote 2,013 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 257 | 285 | 108 | $3,322 |
| Triamcinolone Acetonide Generic | 217 | 242 | 162 | $2,055 |
| Fluorouracil Generic | 209 | 214 | 188 | $16K |
| Clobetasol Propionate Generic | 171 | 179 | 75 | $8,724 |
| Fluocinonide Generic | 124 | 132 | 91 | $3,508 |
| Doxycycline Hyclate Generic | 94 | 139 | 56 | $2,022 |
| Metronidazole Generic | 88 | 90 | 52 | $4,094 |
| Clindamycin Phosphate Generic | 60 | 64 | 23 | $2,159 |
| Desonide Generic | 57 | 58 | 46 | $2,066 |
| Doxycycline Monohydrate Generic | 44 | 62 | 16 | $755 |
| Ivermectin Generic | 36 | 36 | 19 | $12K |
| Cephalexin Generic | 36 | 36 | 32 | $177 |
| Dupixent Pen Dupilumab | 34 | 34 | Under 11 | $125K |
| Tacrolimus Generic | 32 | 32 | 18 | $2,468 |
| Otezla Apremilast | 31 | 35 | Under 11 | $174K |
Brand drugs: 310 claims; generic drugs: 1,703 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert C Anderson $81.81 ($81.81 in general payments such as food, travel and fees) from 4 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $36.28.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.